Kyverna (KYTX) shares dropped 28% amid updated data for its lead CAR-T cell therapy candidate KYV-101 at a rheumatology medical meeting.
https://seekingalpha.com/news/4116261-kyverna-stock-plunges-amid-data-update-on-lead-drug
Kyverna (KYTX) shares dropped 28% amid updated data for its lead CAR-T cell therapy candidate KYV-101 at a rheumatology medical meeting.
https://seekingalpha.com/news/4116261-kyverna-stock-plunges-amid-data-update-on-lead-drug
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.